Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, Fisher M, Pandian J, Lindsay P (2022) World stroke organization (WSO): global stroke fact sheet 2022. Int J Stroke 17:18–29. https://doi.org/10.1177/17474930211065917

Article  PubMed  Google Scholar 

Kehrel BE, Fender AC (2016) Resolving thromboinflammation in the brain after ischemic stroke? Circulation 133:2128–2131. https://doi.org/10.1161/CIRCULATIONAHA.116.022858

Article  PubMed  Google Scholar 

De Meyer SF, Langhauser F, Haupeltshofer S, Kleinschnitz C, Casas AI (2022) Thromboinflammation in brain ischemia: recent updates and future perspectives. Stroke 53:1487–1499. https://doi.org/10.1161/STROKEAHA.122.038733

Article  CAS  PubMed  Google Scholar 

Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer H-U, Burfeind P, Renné C, Gailani D, Nieswandt B, Renné T (2006) Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203:513–518. https://doi.org/10.1084/jem.20052458

Article  CAS  PubMed  PubMed Central  Google Scholar 

Didiasova M, Wujak L, Schaefer L, Wygrecka M (2018) Factor XII in coagulation, inflammation and beyond. Cell Signal 51:257–265. https://doi.org/10.1016/j.cellsig.2018.08.006

Article  CAS  PubMed  Google Scholar 

Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C (2012) In vivo roles of factor XII. Blood 120:4296–4303. https://doi.org/10.1182/blood-2012-07-292094

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renné T, Stavrou EX (2019) Roles of factor XII in innate immunity. Front Immunol 10:2011. https://doi.org/10.3389/fimmu.2019.02011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matafonov A, Leung PY, Gailani AE, Grach SL, Puy C, Cheng Q, Sun M, McCarty OJT, Tucker EI, Kataoka H, Renné T, Morrissey JH, Gruber A, Gailani D (2014) Factor XII Inhibition reduces thrombus formation in a primate thrombosis model. Blood 123:1739–1746. https://doi.org/10.1182/blood-2013-04-499111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Cooley BC, Akinc A, Butler J, Borodovsky A (2020) Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function. Thromb Res 196:200–205. https://doi.org/10.1016/j.thromres.2020.08.040

Article  CAS  PubMed  Google Scholar 

Sparkenbaugh EM, Henderson MW, Miller-Awe M, Abrams C, Ilich A, Trebak F, Ramadas N, Vital S, Bohinc D, Bane KL, Chen C, Patel M, Wallisch M, Renné T, Gruber A, Cooley B, Gailani D, Kasztan M, Vercellotti GM, Belcher JD, Gavins FE, Stavrou EX, Key NS, Pawlinski R (2023) Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood 141:1871–1883. https://doi.org/10.1182/blood.2022017074

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keat Wei L, Griffiths L, Wee Kooi C, Irene L Meta-Analysis of Factor, Factor V (2019) VII, Factor XII, and Factor XIII-A Gene Polymorphisms and Ischemic Stroke. Medicina 55:101. https://doi.org/10.3390/medicina55040101

Zamolodchikov D, Bai Y, Tang Y, McWhirter JR, Macdonald LE, Alessandri-Haber N (2019) A short isoform of coagulation factor XII mRNA is expressed by neurons in the human brain. Neuroscience 413:294–307. https://doi.org/10.1016/j.neuroscience.2019.05.040

Article  CAS  PubMed  Google Scholar 

Shamanaev A, Litvak M, Gailani D (2022) Recent advances in factor XII structure and function. Curr Opin Hematol 29:233–243. https://doi.org/10.1097/MOH.0000000000000727

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stavrou E, Fang C, Bane K, Long A, Naudin C, Kucukal E, Gandhi A, Brett-Morris A, Mumaw M, Izadmehr S, Merkulova A, Reynolds C, Alhalabi O, Nayak L, Yu W-M, Qu C-K, Meyerson H, Dubyak G, Gurkan U, Schmaier A (2018) Factor XII and uPAR upregulate neutrophil functions to influence wound healing. J Clin Invest 128(3):944–959. https://doi.org/10.1172/JCI92880

Article  PubMed  PubMed Central  Google Scholar 

Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T (2009) Platelet polyphosphates are Proinflammatory and procoagulant mediators in vivo. Cell 139:1143–1156. https://doi.org/10.1016/j.cell.2009.11.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ivanov I, Matafonov A, Sun M-F, Cheng Q, Dickeson SK, Verhamme IM, Emsley J, Gailani D (2017) Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood 129:1527–1537. https://doi.org/10.1182/blood-2016-10-744110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maas C, Renné T (2018) Coagulation factor XII in thrombosis and inflammation. Blood 131:1903–1909. https://doi.org/10.1182/blood-2017-04-569111

Article  CAS  PubMed  Google Scholar 

Shamanaev A, Litvak M, Gailani D (2022) Recent advances in factor XII structure and function. Curr Opin Hematol 29(5):233–243. https://doi.org/10.1097/MOH.0000000000000727

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shamanaev A, Litvak M, Ivanov I, Srivastava P, Sun MF, Dickeson SK, Kumar S, He TZ, Gailani D (2024) Factor XII Structure-Function relationships. Semin Thromb Hemost 50(7):937–952. https://doi.org/10.1055/s-0043-1769509

Article  CAS  PubMed  Google Scholar 

Heestermans M, Naudin C, Mailer RK, Konrath S, Klaetschke K, Jämsä A, Frye M, Deppermann C, Pula G, Kuta P, Friese MA, Gelderblom M, Sickmann A, Preston RJS, Nofer J-R, Rose-John S, Butler LM, Salomon O, Stavrou EX, Renné T (2021) Identification of the factor XII contact activation site enables sensitive coagulation diagnostics. Nat Commun 12:5596. https://doi.org/10.1038/s41467-021-25888-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shamanaev A, Ivanov I, Sun M-F, Litvak M, Srivastava P, Mohammed BM, Shaban R, Maddur A, Verhamme IM, McCarty OJT, Law RHP, Gailani D (2022) Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains. Blood Adv 6:3142–3154. https://doi.org/10.1182/bloodadvances.2021005976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frunt R, El Otmani H, Smits S, Clark CC, Maas C (2024) Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody. J Thromb Haemost 22:2562–2575. https://doi.org/10.1016/j.jtha.2024.06.005

Article  CAS  PubMed  Google Scholar 

Clark CC, Hofman ZLM, Sanrattana W, de Maat S, Maas C (2020) The fibronectin type II domain of factor XII ensures Zymogen quiescence. Thromb Haemost 120(3):400–411. https://doi.org/10.1055/s-0039-3402760

Article  PubMed  Google Scholar 

Kaira BG, Slater A, McCrae KR, Dreveny I, Sumya U-M, Mutch NJ, Searle M, Emsley J (2020) Factor XII and kininogen asymmetric assembly with gC1qR/C1QBP/P32 is governed by allostery. Blood 136(14):1685–1697. https://doi.org/10.1182/blood.2020004818

Article  PubMed  Google Scholar 

Henderson LM, Figueroa CD, MüIIer-Esterl W, Bhoola KD (1994) Assembly of Contact-Phase factors on the surface of the human neutrophil membrane. Blood 84:474–482. https://doi.org/10.1182/blood.V84.2.474.474

Article  CAS  PubMed  Google Scholar 

Konings J, Govers-Riemslag JWP, Philippou H, Mutch NJ, Borissoff JI, Allan P, Mohan S, Tans G, Ten Cate H, Ariëns RAS (2011) Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 118:3942–3951. https://doi.org/10.1182/blood-2011-03-339572

Article  CAS  PubMed  Google Scholar 

Sato Y, Sugi T, Sakai R (2019) Ant